The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.
via NYT > Business Day http://ift.tt/1uhMoxy
via WordPress http://ift.tt/1nhnEBr
No comments:
Post a Comment